$135 Million is the total value of Foresite Capital Management V, LLC's 12 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KNTE | New | Kinnate Biopharma Inc. | $34,808,000 | – | 875,001 | +100.0% | 25.78% | – |
| ALXO | New | ALX Oncology Holdings Inc. | $27,584,000 | – | 320,000 | +100.0% | 20.43% | – |
| RLAY | New | Relay Therapeutics, Inc. | $16,624,000 | – | 400,000 | +100.0% | 12.31% | – |
| NRIX | New | Nurix Therapeutics, Inc. | $14,846,000 | – | 451,522 | +100.0% | 11.00% | – |
| OAC | New | Oaktree Acquisition Corp. | $12,723,000 | – | 871,422 | +100.0% | 9.42% | – |
| PHICU | New | Population Health Investment Co., Inc.unit | $10,032,000 | – | 960,000 | +100.0% | 7.43% | – |
| RACA | New | Therapeutics Acquisition Corp | $4,872,000 | – | 350,000 | +100.0% | 3.61% | – |
| BCTG | New | BCTG Acquisition Corp. | $4,576,000 | – | 400,000 | +100.0% | 3.39% | – |
| LSAQ | New | LifeSci Acquisition II Corp. | $4,268,000 | – | 400,000 | +100.0% | 3.16% | – |
| HLXA | New | Helix Acquisition Corp. | $2,843,000 | – | 250,000 | +100.0% | 2.10% | – |
| New | Consonance-HFW Acquisition Corp.unit | $1,047,000 | – | 100,000 | +100.0% | 0.78% | – | |
| ABCL | New | Abcellera Biologics Inc. | $805,000 | – | 20,000 | +100.0% | 0.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Kinnate Biopharma Inc. | 12 | Q3 2023 | 25.8% |
| Hims & Hers Health, Inc. | 11 | Q3 2023 | 37.5% |
| Aclaris Therapeutics, Inc. | 11 | Q3 2023 | 15.4% |
| Pharvaris N.V. | 11 | Q3 2023 | 5.5% |
| Quantum-Si Incorporated | 9 | Q2 2023 | 11.3% |
| TheseusPharmaceuticals, Inc. | 8 | Q3 2023 | 24.4% |
| Somalogic, Inc. | 8 | Q2 2023 | 20.5% |
| Compass Therapeutics, Inc. | 8 | Q3 2023 | 17.2% |
| Pardes Biosciences Inc | 7 | Q2 2023 | 37.8% |
| Gemini Therapeutics, Inc. | 7 | Q3 2022 | 9.7% |
View Foresite Capital Management V, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-05 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-08-31 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-07-19 |
| 13F-HR | 2023-05-12 |
| 4 | 2023-05-10 |
| 4 | 2023-04-06 |
| 4 | 2023-02-22 |
View Foresite Capital Management V, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.